Significant intimal hyperplasia regression between 6 and 18 months following Genous™ endothelial progenitor cell capturing stent placement

International Journal of Cardiology

Volumn 147, Issue 2, 2011, Pages 289-291

  Klomp, Margo ^a   Beijk, Marcel A M ^a   Tijssen, Jan G P ^a   De Winter, Robbert J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Endothelial progenitor cell capturing stent; Intimal regression; PCI; Restenosis

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; CLINICAL ARTICLE; CORONARY STENT; ENDOTHELIAL PROGENITOR CELL; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; LETTER; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT;

EID: 79951956791     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.12.041     Document Type: Article

References (21)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science Feb. 14 1997;275(5302):964-7. (Pubitemid 27087709)
2. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res Aug. 6 1999;85(3):221-8. (Pubitemid 29377293)
3. Kutryk MJ, kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol 2003;92 (6A):94L-5L.
4. Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor seeding of stented arterial segments and vascular grafts. Circulation 2003;108(suppl):IV- 573.
5. Kutryk MJ, Kuliszewski MA. The future beyond drug eluting stents: endothelial cell capture. Int Symp Endovas Ther 2004:125-9 Course syllabus.
6. Aoki J, Ong AT, Abizaid A, et al. One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES). EuroIntervention Aug. 2005;1(2):165-72.
7. Duckers HJ, Silber S, de WR, et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention May 2007;3(1):67-75.
8. Duckers HJ, Soullie T, Den HP, et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention Nov. 2007;3(3):350-8.
9. Asakura M, Ueda Y, Nanto S, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation May 26 1998;97(20):2003-6. (Pubitemid 28243660)
10. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation Jan. 5 1999;99(1):44-52. (Pubitemid 29035956)
11. Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented human coronary arteries. Circulation Aug. 24 2004;110(8):940-7. (Pubitemid 39128619)
12. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol Jan. 2000;35(1):157-63. (Pubitemid 30061274)
13. Hermiller JB, Fry ET, Peters TF, et al. Late coronary artery stenosis regression within the Gianturco-Roubin intracoronary stent. Am J Cardiol Feb. 1 1996;77(4):247-51. (Pubitemid 26059291)
14. Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med Feb. 29 1996;334(9):561-6. (Pubitemid 26066129)
15. Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis Sep. 2004;15(6):313-8. (Pubitemid 39299245)
16. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol Jul. 4 2006;48(1):193-202. (Pubitemid 43929240)
17. Aoki J, Abizaid AC, Serruys PW, et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol Nov. 1 2005;46 (9):1670-6. (Pubitemid 41531621)
18. Morice MC, Serruys PW, Barragan P, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol Oct. 2 2007;50(14):1299-304. (Pubitemid 47454687)
19. Fajadet J, Wijns W, Laarman GJ, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiol Feb. 2007;55(1):1-18. (Pubitemid 46480820)
20. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitax-eleluting stents for coronary revascularization. N Engl J Med Aug. 18 2005;353(7):653-62. (Pubitemid 41175673)
21. Shewan LG and Coats AJ. Ethics in the authorship and publishing of scientific articles Int J Cardiol 2010;144:1-2.